| 000 | 01139 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516164047.0 | ||
| 264 | 0 | _c20131118 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/STROKEAHA.113.002158 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Meijuan | |
| 245 | 0 | 0 |
_aResponse to letter regarding article, "CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China". _h[electronic resource] |
| 260 |
_bStroke _cSep 2013 |
||
| 300 |
_ae108 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xgenetics |
| 650 | 0 | 4 |
_aAsian People _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 650 | 0 | 4 |
_aTiclopidine _xanalogs & derivatives |
| 700 | 1 | _aXu, Yun | |
| 773 | 0 |
_tStroke _gvol. 44 _gno. 9 _gp. e108 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/STROKEAHA.113.002158 _zAvailable from publisher's website |
| 999 |
_c23002199 _d23002199 |
||